Biocompatible nanoparticles modified with ATP can enhance systemic delivery of cancer immunotherapy
Purdue University researchers are developing and validating patent-pending poly (lactic-co-glycolic acid), or PLGA, nanoparticles modified with adenosine triphosphate, or ATP, to enhance immunotherapy effects against malignant ...